Prostate Cancer Survey

There was an error on your page. Please correct any required fields and submit again. Go to the first error
1. Do you have a CyberKnife® System at your institution?
2. Which tumor types/disease areas do you (or would you) treat with the CyberKnife® System? (Select all that apply.)
3. Which of the following treatment options are you offering to low-risk prostate cancer patients? (Select all that apply.)
4. Which of the following treatment options are you offering to intermediate-risk prostate cancer patients? (Select all that apply.)
5. Which of the following treatment options are you offering to high-risk prostate cancer patients (select all that apply)?
6. Would you change how you treat low-risk prostate cancer based on an SBRT prospective multi-institutional trial with 5-year median follow up?
7. Would you change how you treat intermediate-risk prostate cancer based on an SBRT prospective multi-institutional trial with 5-year median follow up?
8. Are you aware of the prospective multi-institutional trial recently presented at ASTRO on CyberKnife® prostate SBRT for low and intermediate risk patients with 5-year median follow up?
9. Do you believe the results from a prostate SBRT prospective study where all patients were treated with the CyberKnife® System apply to patients treated on other radiotherapy systems?
10. Do you believe other radiotherapy systems with SBRT capability are equivalent to the CyberKnife® system for prostate SBRT?
11. How important is Cyberknife intra-fraction tracking and automatic beam correction for prostate SBRT?
12. How satisfied are you with the data that support Cyberknife prostate SBRT safety and efficacy?
13. Would you like to be informed of the latest clinical data?
14. What is the best way to share with you the latest clinical data publications? (Select all that apply.)
14. Would you like to participate in a national co-op advertising program on CyberKnife prostate SBRT if one was available?